Reference
1 Fatima Amanat, Kris M White, Lisa Miorin, et al. An In Vitro Microneutralization Assay for SARS-CoV-2 Serology and Drug Screening. Curr Protoc Microbiol 2020 Sep;58(1):e108.
2 Jun-Gyu Park, Fatai S. Oladunni, Kevin Chiem, et al. Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2. J Virol Methods. 2021 Jan;287:113995.
3 Zhenhao Fang, Lei Peng, Renata Filler, et al. Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2. Nat Commun.2022 Jun 6;13(1):3250.
4 Bin Ju, Qi Zhang, Jiwan Ge, et al Human neutralizing antibodies elicited by SARS-CoV-2 infection. Nature 2020,584, 115-119.
5 Heli Harvala, Matthew L. Robb, Nick Watkins, Convalescent plasma therapy for the treatment of patients with COVID-19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levels Transfusion Medicine.2021;31:167-175.
6 Weidner L, Gänsdorfer S, Unterweger S, et al. Quantification of SARS‐CoV‐2 antibodies with eight commercially available immunoassays. J Clin Virol.2020;129:104540.
7 Llipsy Santiago, Iratxe Uranga-Murillo 1, Maykel Arias 2, Andrés Manuel González-Ramírez, et al. Determination of the Concentration of IgG against the Spike Receptor-Binding Domain That Predicts the Viral Neutralizing Activity of Convalescent Plasma and Serum against SARS-CoV-2 Biology 2021, 10, 208.
8 Nie J,Li Q, Wu J, et al. Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2. Emerg Microbes Infect.2020;9:680-686.
9 Srijan Chatterjee, Manojit Bhattacharya, Sagnik Nag, et al. A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies. Viruses.2023 Jan 5;15(1):167.
10 Aekkachai Tuekprakhon , Rungtiwa Nutalai, et al.Aiste Dijokaite-Guraliuc, Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum. Cell. 2022 Jul 7; 185(14): 2422-2433.e13.
11 Dejnirattisai W, Shaw RH, Supasa P, et al. Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum. Lancet 2022; 399: 234-36.
12 Pajon R, Doria-Rose NA, Shen X, et al. SARS-CoV-2 omicron variant neutralization after mRNA-1273 booster vaccination. N Engl J Med 2022; 386: 1088-91.
13 Dolscheid-Pommerich R, Bartok E, Renn M, Kümmerer BM, et al. Correlation between a quantitative anti-SARS-CoV-2 IgG ELISA and neutralization activity. J Med Virol. 2022 Jan;94(1):388-392.